Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change
Background. COVID-19 interacts at multiple levels with the cardiovascular system. The prognosis of COVID-19 infection is known to be worse for patients with underlying cardiovascular diseases. Furthermore, the virus is responsible for many cardiovascular complications. Myocardial injury may affect u...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2020/4348598 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556893986357248 |
|---|---|
| author | Nadia Benyounes Clélie Van Der Vynckt Séverine Tibi Alexandra Iglesias Laurence Salomon Olivier Gout Thierry Tibi |
| author_facet | Nadia Benyounes Clélie Van Der Vynckt Séverine Tibi Alexandra Iglesias Laurence Salomon Olivier Gout Thierry Tibi |
| author_sort | Nadia Benyounes |
| collection | DOAJ |
| description | Background. COVID-19 interacts at multiple levels with the cardiovascular system. The prognosis of COVID-19 infection is known to be worse for patients with underlying cardiovascular diseases. Furthermore, the virus is responsible for many cardiovascular complications. Myocardial injury may affect up to 20% of the critically ill patients. However, echocardiography’s impact on the management of patients affected by COVID-19 remains unknown. Objectives. To explore echocardiography’s impact on the management of COVID-19 patients. Methods. This study was conducted from March 24th to April 14th, 2020, in a single center at Adolphe de Rothschild Foundation Hospital, Paris, France. All consecutive inpatients with laboratory and/or CT COVID-19 diagnosis were included in this study. Patients’ characteristics (clinical, biological, and imaging) and treatment change induced by echocardiography were collected and analyzed. Patients with and without treatment change induced by echocardiography were compared. Results. A total of 56 echocardiographies in 42 patients with highly suspected or confirmed COVID-19 were included in the final analyses. The median age was 66 (IQR 60.5–74). Echocardiography induced a treatment change in 9 cases (16%). The analyzed clinical data were not associated with any treatment change induced by echocardiography. D-dimer and Troponin levels were the only biological predictors of the induced treatment change. On echocardiography, higher systolic pulmonary arterial pressure and documented cardiac thrombi were associated with treatment changes in these patients. Conclusions. Echocardiography may be useful for the management of selected COVID-19 patients, especially those with elevated D-Dimer and Troponin levels, in up to 16% of patients. |
| format | Article |
| id | doaj-art-686142af58a444f48534b6de45396f49 |
| institution | Kabale University |
| issn | 2090-8016 2090-0597 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiology Research and Practice |
| spelling | doaj-art-686142af58a444f48534b6de45396f492025-02-03T05:44:12ZengWileyCardiology Research and Practice2090-80162090-05972020-01-01202010.1155/2020/43485984348598Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment ChangeNadia Benyounes0Clélie Van Der Vynckt1Séverine Tibi2Alexandra Iglesias3Laurence Salomon4Olivier Gout5Thierry Tibi6Cardiology Unit, Rothschild Foundation Hospital, Paris, FranceCardiology Unit, Rothschild Foundation Hospital, Paris, FranceBritish Library, London, UKAlsacienne School, Paris, FranceClinical Research Department, Rothschild Foundation Hospital, Paris, FranceNeurology Department, Rothschild Foundation Hospital, Paris, FranceCardiology Unit, Rothschild Foundation Hospital, Paris, FranceBackground. COVID-19 interacts at multiple levels with the cardiovascular system. The prognosis of COVID-19 infection is known to be worse for patients with underlying cardiovascular diseases. Furthermore, the virus is responsible for many cardiovascular complications. Myocardial injury may affect up to 20% of the critically ill patients. However, echocardiography’s impact on the management of patients affected by COVID-19 remains unknown. Objectives. To explore echocardiography’s impact on the management of COVID-19 patients. Methods. This study was conducted from March 24th to April 14th, 2020, in a single center at Adolphe de Rothschild Foundation Hospital, Paris, France. All consecutive inpatients with laboratory and/or CT COVID-19 diagnosis were included in this study. Patients’ characteristics (clinical, biological, and imaging) and treatment change induced by echocardiography were collected and analyzed. Patients with and without treatment change induced by echocardiography were compared. Results. A total of 56 echocardiographies in 42 patients with highly suspected or confirmed COVID-19 were included in the final analyses. The median age was 66 (IQR 60.5–74). Echocardiography induced a treatment change in 9 cases (16%). The analyzed clinical data were not associated with any treatment change induced by echocardiography. D-dimer and Troponin levels were the only biological predictors of the induced treatment change. On echocardiography, higher systolic pulmonary arterial pressure and documented cardiac thrombi were associated with treatment changes in these patients. Conclusions. Echocardiography may be useful for the management of selected COVID-19 patients, especially those with elevated D-Dimer and Troponin levels, in up to 16% of patients.http://dx.doi.org/10.1155/2020/4348598 |
| spellingShingle | Nadia Benyounes Clélie Van Der Vynckt Séverine Tibi Alexandra Iglesias Laurence Salomon Olivier Gout Thierry Tibi Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change Cardiology Research and Practice |
| title | Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change |
| title_full | Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change |
| title_fullStr | Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change |
| title_full_unstemmed | Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change |
| title_short | Echocardiography in Confirmed and Highly Suspected Symptomatic COVID-19 Patients and Its Impact on Treatment Change |
| title_sort | echocardiography in confirmed and highly suspected symptomatic covid 19 patients and its impact on treatment change |
| url | http://dx.doi.org/10.1155/2020/4348598 |
| work_keys_str_mv | AT nadiabenyounes echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange AT clelievandervynckt echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange AT severinetibi echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange AT alexandraiglesias echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange AT laurencesalomon echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange AT oliviergout echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange AT thierrytibi echocardiographyinconfirmedandhighlysuspectedsymptomaticcovid19patientsanditsimpactontreatmentchange |